TJP1 Contributes to Tumor Progression through Supporting Cell-Cell Aggregation and Communicating with Tumor Microenvironment in Leiomyosarcoma-Reference-Cited by-同舟云学术

TJP1 Contributes to Tumor Progression through Supporting Cell-Cell Aggregation and Communicating with Tumor Microenvironment in Leiomyosarcoma

Published:2021-11-30 Issue:11 Volume:44 Page:784-794
ISSN:0219-1032
Container-title:Molecules and Cells
language:en
Short-container-title:Mol.Cells

Author:

Lee Eun-Young¹²^ORCID,Kim Minjeong¹^ORCID,Choi Beom K.³^ORCID,Kim Dae Hong⁴^ORCID,Choi Inho²^ORCID,You Hye Jin¹⁵^ORCID

Affiliation:

1. Division of Translational Science, Research Institute, National Cancer Center, Goyang 10408, Korea

2. Department of Medical Biotechnology, Yeungnam University, Gyeongsan 38541, Korea

3. Biomedicine Production Branch, Research Institute, National Cancer Center, Goyang 10408, Korea

4. Division of Convergence Technology, Research Institute, National Cancer Center, Goyang 10408, Korea

5. Department of Cancer Biomedical Science, National Cancer Center-Graduate School of Cancer Science and Policy (NCC-GCSP), National Cancer Center, Goyang 10408, Korea

Publisher

Korean Society for Molecular and Cellular Biology

Subject

Cell Biology,Molecular Biology,General Medicine

Link

http://pdf.medrang.co.kr/KSMCB/2021/044/KSMCB044-11-02.pdf

Reference49 articles.

1. PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma

2. Heatmapper: web-enabled heat mapping for all

3. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy

4. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas

5. Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC)

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Assessment of miR-185-5p and miR-191-5p Expression: From Normal Endometrium to High-Grade Endometrial Cancer;Cells;2024-06-25

2. Novel chromium (III)-based compound for inhibition of oxaliplatin-resistant colorectal cancer progression;American Journal of Cancer Research;2024

3. Sarcoma Immunotherapy: Confronting Present Hurdles and Unveiling Upcoming Opportunities;Molecules and Cells;2023-10

4. New established cell lines from undifferentiated pleomorphic sarcoma for in vivo study;BMB Reports;2023-02-20

5. Tight Junction Protein 1 Suppresses Kidney Renal Clear Cell Carcinoma Cells Proliferation by Inducing Autophagy;International Journal of Medical Sciences;2023